USPTO 2015–2025 USPTO PatentsView US Corporation

Hoffmann-La Roche Inc.

USPTO PatentsView assignee record — 1,065 granted patents across 64 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

1,065
Total patents granted
64
CPC technology areas
16.2
Avg claims per patent
+10%
5-year filing velocity

Portfolio overview

Hoffmann-La Roche Inc. has been granted 1,065 US utility patents between 2015 and 2025, placing Hoffmann-La Roche Inc. at rank #425 across all assignees tracked by PlainPatent. This portfolio spans 64 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a US Corporation, Hoffmann-La Roche Inc. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 65.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 559 grants, compared with 506 in the 2015–2019 window — a +10% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Hoffmann-La Roche Inc.'s 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 64 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hoffmann-La Roche Inc. against peers pursuing similar technology classes.

How does Hoffmann-La compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Hoffmann-La holds 1,065 patents — placing it at rank #425 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

6080100120140 20152016201720182019202020212022202320242025 72
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Hoffmann-La Roche Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 74 6.9%
2016 122 11.5%
2017 108 10.1%
2018 104 9.8%
2019 98 9.2%
2020 105 9.9%
2021 92 8.6%
2022 113 10.6%
2023 83 7.8%
2024 94 8.8%
2025 72 6.8%

Patent Moat Analysis

Portfolio Volume Strong
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#425

Across all tracked assignees

Innovation Score

65.3 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Hoffmann-La Roche Inc. hold?
Hoffmann-La Roche Inc. holds 1,065 US granted patents filed between 2015 and 2025, spanning 64 technology areas.
What is Hoffmann-La Roche Inc.'s Innovation Score?
Hoffmann-La Roche Inc. has an Innovation Score of 65.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Hoffmann-La Roche Inc. focus on?
Hoffmann-La Roche Inc.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 722 patents. The company has filed patents in 64 CPC subclasses total.
Is Hoffmann-La Roche Inc.'s patent filing rate increasing or decreasing?
Hoffmann-La Roche Inc.'s recent filing velocity is +10% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Hoffmann-La Roche Inc.'s patents?
Hoffmann-La Roche Inc.'s patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Hoffmann-La Roche Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope